title: FDA notifications.  Intron label change approved by FDA.
mesh_terms: D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D001523:Mental Disorders / Q000139:chemically induced / Q000523:psychology; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b